Fig. 12
From: Comprehensive tumor molecular profile analysis in clinical practice
Patients' categorization based on the level of evidence of the most clinically significant variant associated with response, with and without the use of immunotherapy biomarkers. Biomarkers associated with resistance were excluded from this analysis